Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory Experts React As UK Gov Asks Heavy Engineering Firms To Produce Ventilators

Executive Summary

Medtech regulatory parameters could be shifting as the UK makes an unprecedented call for other industries to produce ventilators to deal with the current COVID-19 situation.

You may also be interested in...



Potential Liability Issues With Emergency Use Ventilators In UK: A Lawyer’s Viewpoint

Having non-medtech manufacturers develop and deliver ventilators for use on COVID-19 patients has alarmed many regulatory experts in the medtech industry. What are the potential liability issues and under what conditions can these new products remain on the market? Sarah Cowlishaw and Grant Castle of law firm Covington & Burling give their views.

Notified Body Expert Akra Calls For Special Taskforce Measures To Oversee New COVID-19 Products

With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.

Ford Races To The Rescue: US Auto Maker Partners With GE, 3M To Make Ventilators, Respirators During COVID-19 Crisis

Ford Motor Co. announced partnerships on 24 March with GE Healthcare and 3M Co. to manufacture much-needed medical ventilators and respirators. The auto maker also said it’s developing and testing plastic face shields for health care workers.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT126392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel